These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3313522)

  • 21. Identification of low-molecular-weight protein (SCP1) from shark cartilage with anti-angiogenesis activity and sequence similarity to parvalbumin.
    Rabbani-Chadegani A; Abdossamadi S; Bargahi A; Yousef-Masboogh M
    J Pharm Biomed Anal; 2008 Feb; 46(3):563-7. PubMed ID: 18093782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical perspective of angiogenesis inhibitors].
    Radema SA; Witteveen PO; Gebbink MB; Voest EE
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a quantitative mouse dorsal air sac model and its application to evaluate a new angiogenesis inhibitor.
    Funahashi Y; Wakabayashi T; Semba T; Sonoda J; Kitoh K; Yoshimatsu K
    Oncol Res; 1999; 11(7):319-29. PubMed ID: 10757446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
    Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
    Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of agmatine on proliferation of tumor cells by modulation of polyamine metabolism.
    Wang JF; Su RB; Wu N; Xu B; Lu XQ; Liu Y; Li J
    Acta Pharmacol Sin; 2005 May; 26(5):616-22. PubMed ID: 15842783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional anti-angiogenesis therapy of human pancreatic cancer.
    Xie K; Wei D; Huang S
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):147-56. PubMed ID: 16516532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of B16 melanoma growth in vivo by retroviral vector-mediated human ribonuclease inhibitor.
    Wang T; Yang M; Chen J; Watkins T; Xiuyun C
    Angiogenesis; 2005; 8(1):73-81. PubMed ID: 16132620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenic inhibitor protein fractions derived from shark cartilage.
    Bargahi A; Rabbani-Chadegani A
    Biosci Rep; 2008 Feb; 28(1):15-21. PubMed ID: 18215148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-angiogenesis strategies in cancer].
    Fons P; Malavaud B; Venat L; Plouet J
    Bull Acad Natl Med; 2000; 184(3):579-86; discussion 586-7. PubMed ID: 10989554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
    Ojo-Amaize EA; Nchekwube EJ; Cottam HB; Bai R; Verdier-Pinard P; Kakkanaiah VN; Varner JA; Leoni L; Okogun JI; Adesomoju AA; Oyemade OA; Hamel E
    Cancer Res; 2002 Jul; 62(14):4007-14. PubMed ID: 12124334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of nonpeptidic topomimetics of antiangiogenic proteins with antitumor activities.
    Dings RP; Chen X; Hellebrekers DM; van Eijk LI; Zhang Y; Hoye TR; Griffioen AW; Mayo KH
    J Natl Cancer Inst; 2006 Jul; 98(13):932-6. PubMed ID: 16818857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of intraorganismal systemic communications during carcinogenesis.
    Shabalkin IP; Minaev VI; Shabalkin PI; Yagubov AS
    Dokl Biol Sci; 2000; 375():671-6. PubMed ID: 11211522
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neoplasms under control with the help of vascular treatment?].
    Laurén J; Alitalo K
    Duodecim; 2000; 116(7):705-11. PubMed ID: 12078136
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor angiogenesis in melanoma.
    Marneros AG
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):431-46, vii-viii. PubMed ID: 19464595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and prostate cancer tumor growth.
    Nicholson B; Theodorescu D
    J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage.
    Pufe T; Petersen WJ; Miosge N; Goldring MB; Mentlein R; Varoga DJ; Tillmann BN
    Matrix Biol; 2004 Aug; 23(5):267-76. PubMed ID: 15464359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Angiogenesis and anti-angiogenesis in human neoplasms. Recent developments and the therapeutic prospects].
    Vacca A; Ribatti D; Pellegrino A; Dammacco F
    Ann Ital Med Int; 2000; 15(1):7-19. PubMed ID: 10842887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide.
    Cao QZ; Lin ZB
    Acta Pharmacol Sin; 2004 Jun; 25(6):833-8. PubMed ID: 15169641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.